Hypoxia down-regulates CCAAT/enhancer binding protein-α expression in breast cancer cells

Cancer Research

Volumn 68, Issue 7, 2008, Pages 2158-2165

  Seifeddine, Ramzi ^a,b,c,d   Dreiem, Anne ^a,b   Blanc, Etienne ^c,d   Fulchignoni Lataud, Marie Claude ^c,d   Belda, Marie Aude Le Frère ^d,e   Lecuru, Fabrice ^d,e   Mayi, Thérèse Hervèe ^a,b   Mazure, Nathalie ^g   Favaudon, Vincent ^a,b   Massaad, Charbel ^d,f   Barouki, Robert ^c,d,e   Massaad Massade, Liliane ^a,b,h  

^a INSERM U612   (France)

^b INSTITUT CURIE   (France)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f CNRS   (France)

^g CENTRE ANTOINE LACASSAGNE   (France)

^h PR2   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; CCAAT ENHANCER BINDING PROTEIN ALPHA; DEFEROXAMINE; ESTROGEN; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; OXYGEN; RNA POLYMERASE II; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CELL NUCLEUS; CYTOPLASM; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA STABILITY; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, WESTERN; BREAST NEOPLASMS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL CYCLE; CELL GROWTH PROCESSES; CELL HYPOXIA; CELL LINE, TUMOR; DEFEROXAMINE; DOWN-REGULATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SUBCELLULAR FRACTIONS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 42049090352     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-1190     Document Type: Article

References (35)

1. Zahnow CA. CCAAT/enhancer binding proteins in normal mammary development and breast cancer. Breast Cancer Res 2002;4:113-21.
2. Hendricks-Taylor LR, Darlington GJ. Inhibition of cell proliferation by C/EBPα occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen. Nucleic Acids Res 1995;23:4726-33.
3. Slomiany BA, D'Arigo KL, Kelly MM, Kurtz DT. C/EBPα inhibits cell growth via direct repression of E2F-DP-mediated transcription. Mol Cell Biol 2000;20:5986-97.
4. Timchenko NA, Wilde M, Nakanishi M, Smith JR, Darlington GJ. CCAAT/enhancer-binding protein α (C/EBPα) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev 1996;10:804-15.
5. Umek RM, Friedman AD, McKnight SL. CCAAT-enhancer binding protein: a component of a differentiation switch. Science 1991;251:288-92.
6. Wang H, Iakova P, Wilde M, et al. C/EBPα arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol Cell 2001;8:817-28.
7. Gery S, Tanosaki S, Bose S, Bose N, Vadgama J, Koeffler HP. Down-regulation and growth inhibitory role of C/EBPα in breast cancer. Clin Cancer Res 2005;11:3184-90.
8. Seagroves TN, Krnacik S, Raught B, et al. C/EBPβ, but not C/EBPα, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Dev 1998;12:1917-28.
9. Halmos B, Huettner CS, Kocher O, Ferenczi K, Karp DD, Tenen DG. Down-regulation and antiproliferative role of C/EBPα in lung cancer. Cancer Res 2002;62:528-34.
10. Mueller BU, Pabst T. C/EBPα and the pathophysiology of acute myeloid leukemia. Curr Opin Hematol 2006;13:7-14.
11. Shim M, Powers KL, Ewing SJ, Zhu S, Smart RC. Diminished expression of C/EBPα in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPα in carcinoma cells inhibits proliferation. Cancer Res 2005;65:861-7.
12. Pabst T, Mueller BU, Zhang P, et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia. Nat Genet 2001;27:263-70.
13. Tan EH, Hooi SC, Laban M, et al. CCAAT/enhancer binding protein α knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma. Cancer Res 2005;65:10330-7.
14. Seifeddine R, Dreiem A, Tomkiewicz C, et al. Hypoxia and estrogen co-operate to regulate gene expression in T-47D human breast cancer cells. J Steroid Biochem Mol Biol 2007;104:169-79.
15. Williams KJ, Cowen RL, Stratford IJ. Hypoxia and oxidative stress. Tumour hypoxia-therapeutic considerations. Breast Cancer Res 2001;3:328-31.
16. Helczynska K, Kronblad A, Jogi A, et al. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res 2003;63:1441-4.
17. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999;15:551-78.
18. 2 tension. Proc Natl Acad Sci U S A 1995;92:5510-4.
19. Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 1999;59:5830-5.
20. Zandomeni R, Mittleman B, Bunick D, Ackerman S, Weinmann R. Mechanism of action of dichloro-β-D-ribofuranosylbenzimidazole: effect on in vitro transcription. Proc Natl Acad Sci U S A 1982;79:3167-70.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 2001;25:402-8.
22. Timchenko N, Wilson DR, Taylor LR, et al. Autoregulation of the human C/EBPα gene by stimulation of upstream stimulatory factor binding. Mol Cell Biol 1995;15:1192-202.
23. Sowter HM, Raval RR, Moore JW, Ratcliffe PJ, Harris AL. Predominant role of hypoxia-inducible transcription factor (Hif)-1α versus Hif-2α in regulation of the transcriptional response to hypoxia. Cancer Res 2003;63:6130-4.
24. Erin N, Bronson SK, Billingsley ML. Calcium-dependent interaction of calcineurin with Bcl-2 in neuronal tissue. Neuroscience 2003;117:541-55.
25. Massaad-Massade L, Navarro S, Krummrei U, Reeves R, Beaune P, Barouki R. HMGA1 enhances the transcriptional activity and binding of the estrogen receptor to its responsive element. Biochemistry 2002;41:2760-8.
26. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
27. Zhao X, Teng LZ, Wang ZG, Xin T, Wei SC. Expression and significance of glucocorticoid receptor α in meningiomas. J Clin Neurosci 2007;14:359-63.
28. Bos R, van Der Hoeven JJ, van Der Wall E, et al. Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol 2002;20:379-87.
29. Yeo EJ, Chun YS, Park JW. New anticancer strategies targeting HIF-1. Biochem Pharmacol 2004;68:1061-9.
30. Bosco MC, Puppo M, Pastorino S, et al. Hypoxia selectively inhibits monocyte chemoattractant protein-1 production by macrophages. J Immunol 2004;172:1681-90.
31. Takemoto M, Sun J, Hiroki J, Shimokawa H, Liao JK. Rho-kinase mediates hypoxia-induced down-regulation of endothelial nitric oxide synthase. Circulation 2002;106:57-62.
32. Chen B, Lam KS, Wang Y, et al. Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. Biochem Biophys Res Commun 2006;341:549-56.
33. Jiang Y, Xue ZH, Shen WZ, et al. Desferrioxamine induces leukemic cell differentiation potentially by hypoxia-inducible factor-1α that augments transcriptional activity of CCAAT/enhancer-binding protein-α. Leukemia 2005;19:1239-47.
34. Lin FT, Lane MD. CCAAT/enhancer binding protein α is sufficient to initiate the 3T3-1 adipocyte differentiation program. Proc Natl Acad Sci U S A 1994;91:8757-61.
35. Wang ND, Finegold MJ, Bradley A, et al. Impaired energy homeostasis in C/EBPα knockout mice. Science 1995;269:1108-12.